
Pharmaceutical giant Johnson & Johnson has been ordered to pay $55 million to an American woman who says the company’s talcum powder caused her to develop ovarian cancer.
Following a three-week-long trial in Missouri, jurors decided on Monday in favor of Gloria Ristesund, Reuters reports. The 62-year-old plaintiff said she had used the company’s talc-based powders as feminine hygiene products for decades. According to her lawyers, she developed ovarian cancer and had to get a hysterectomy.
The decision follows a previous case in the same court in February, in which a family of a woman who died of ovarian cancer was awarded $72 million.
According to Reuters, the company is facing 1,2000 similar lawsuits, accusing the Johnson & Johnson of not adequately warning its consumers about the cancer risks to its talcum-based products, which include Baby Powder and Shower to Shower Powder.
J&J, reports Reuters, says its cosmetic talc is safe and that Monday’s verdict at the Missouri state court contradicts 30 years of research. The company intends to appeal the jury decision.
[Reuters]
More Must-Reads from TIME
- Inside Elon Musk’s War on Washington
- Introducing the 2025 Closers
- Colman Domingo Leads With Radical Love
- Why, Exactly, Is Alcohol So Bad for You?
- The Motivational Trick That Makes You Exercise Harder
- 11 New Books to Read in February
- How to Get Better at Doing Things Alone
- Column: Trump’s Trans Military Ban Betrays Our Troops
Contact us at letters@time.com